Aibili Logo Association for Innovation and Biomedical Research on Light

Publications


2017

Lorenz K, Scheller Y, Katharina B, Franz G, Katharina P, Felix B, Crusiefen C, Flach J, Gehring M, Peto T, Silva R, Tal Y, Pfeiffer A prospective, randomized, placebo-controlled, double-masked, three-armed, multicenter phase II/III trial for the Study of a Topic Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Gaucoma - the STRONG study: study protocol for a randomised Controlled Trial. Lorenzo et al.Trials (2017);18:128 [more info]

Figueira J, Henriques J, Amaro M, Rosas V, Alves D, Cunha-Vaz J A non-randomised, open-label, multicenter phase 4 pilot study on the effect and safety of ILUVIEN® in chronic diabetic macular edema patients considered insufficiently responsive to available therapies (RESPOND). Ophthalmic Research Published online DOI: 10.1159/000455235; [more info]

Simão S, Costa MÂ, Sun JK, Cunha-Vaz J, Simó R; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Development of a Normative Database for Multifocal Electroretinography in the Context of a Multicenter Clinical Trial. Ophthalmic Res. 2017;57(2):107-117. doi: 10.1159/000450958. [more info]

Soares M, Neves C, Marques IP, Pires I, Schwartz C, Costa MÂ, Santos T, Durbin M, Cunha-Vaz J. Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography. Br J Ophthalmol. 2017 Jan;101(1):62-68. doi: 10.1136/bjophthalmol-2016-309424. [more info]

Alves C, Ribeiro I, Penedones A, Mendes D, Batel Marques F Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-Analysis Ophthalmic Res. 2016 Jul 13;57(1):60-69. DOI:10.1159/000446845 [more info]

2016

Ribeiro L, Oliveira CM, Neves C, Ramos JD, Ferreira H, Lobo C, Figueira J, Silva R, Cunha-Vaz J Rastreio da Retinopatia Diabética. Importância do Sistema de Classificação Automática. In: Vilela MAP, Putz C, Dantas AM. Retina Clínica. Texto e Atlas. Rio de Janeiro, Cultura Médica, 2016, p.395-411. ISBN 978-85-7006-668-8 [more info]

Batel Marques F, Penedones A, Mendes D, Alves C. Outcomes from the first 6 years of operation of the Central Portugal Pharmacovigilance Unit. J Patient Saf. 2016 Dec 16. doi:10.1097/PTS.0000000000000273. [more info]

Sagwa EL, Souverein Pc, Ribeiro I, Leufkens HG, Mantel-Teeuwisse AK. Differences in VigiBase reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment. Pharmacoepidemiol Drug Saf. 2016 Nov 20. doi:10.1002/pds.4125. [more info]

Batel Marques F, Penedones A, Mendes D, Alves C. A systematic review of observational studies evaluating costs of adverse drug reactions. Clinicoecon Outcomes Res. 2016 Aug 24;8:413-26. doi:10.2147/CEOR.S115689. [more info]

Mendes D, Alves C, Batel Marques F. Benefit-risk of therapies for relapsing-remitting multiple sclerosis: testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat Harm (NNTH) and the likelihood to be helped or harmed (LHH): a systematic review and meta-analysis. CNS Drugs. 2016 Oct;30(10):909-29. doi:10.1007/s40263-016-0377-9. [more info]

« Previous 1 2 3 4 5 ... 35 Next »

Publications by department:



Publications by year:

Copyright © 2017 AIBILI   -   Contact Us   -   Site Map   -   Webdesign Glitz Design   -   Programming Bizview